Syndicate Bio
PrivateLast Round
Pre Seed
May 23, 2025
Total Funding Raised
$120,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Syndicate Bio is a biotechnology company that operates as a platform for genomics and precision medicine initiatives, with a primary focus on Africa.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syndicate Bio Comparables
Compare Syndicate Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyAfroDNA | 86% | |
| IndyGeneUS Bio | 85% | |
| BixBio | 84% |
Syndicate Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 23, 2025 | ||||
| Accelerator | Sep 9, 2024 |
Syndicate Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AUDA-NEPAD | Pre Seed |
| Techstars | Pre Seed, Accelerator |
| Belal Badat Ventures | Accelerator |
| Nubia Capital | Accelerator, Pre Seed |
| StoryHouse Ventures | Accelerator, Pre Seed |
| UNT Health Science Center | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 22% QoQ, from 18 to 22 employees.
- May 17, 2026
Monthly visitors grew 99% MoM, reaching 3.9K.
Syndicate Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Syndicate Bio's valuation, stock price, and market status.
Is Syndicate Bio a public or private company?
Syndicate Bio is a private company.
What is the current stock price of Syndicate Bio?
Syndicate Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Syndicate Bio worth (valuation)?
Valuation information for Syndicate Bio is not publicly available.
Can I buy Syndicate Bio stock?
Syndicate Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Syndicate Bio's last funding round?
Syndicate Bio's most recent funding round was VC Round on May 20, 2025.
Who are the main investors in Syndicate Bio?
Key investors in Syndicate Bio include Techstars.
Will Syndicate Bio IPO soon?
No public IPO plans have been announced for Syndicate Bio.
How can I track Syndicate Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Syndicate Bio's secondary market activity and sign up for updates.